Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of Dorsomorphin: The discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe

Documenti analoghi

• In Vivo Structure Activity Relationship Study of Dorsomorphin Analogs Identifies Selective VEGF and BMP Inhibitors
  di: Hao, Jijun, et al.
  Pubblicazione: (2010)
• Discovery of 3-(4-sulfamoylnaphthyl)pyrazolo[1,5-a]pyrimidines as potent and selective ALK2 inhibitors
  di: Jiang, Jian-kang, et al.
  Pubblicazione: (2018)
• Development of a more highly selective M(1) antagonist from the continued optimization of the MLPCN Probe ML012
  di: Melancon, Bruce J., et al.
  Pubblicazione: (2011)
• Spirocyclic replacements for the isatin in the highly selective, muscarinic M(1) PAM ML137: the continued optimization of an MLPCN probe molecule
  di: Poslusney, Michael S., et al.
  Pubblicazione: (2013)
• Isatin replacements applied to the highly selective, muscarinic M(1) PAM ML137: Continued optimization of an MLPCN probe molecule
  di: Melancon, Bruce J., et al.
  Pubblicazione: (2012)